Clinical trials
Male clinical trials
Below are recruiting male clinical trials, each written for real people, not researchers. We’re tracking 231 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07327359RecruitingPhase 1/Phase 2
Study of OLX72021 for male pattern baldness
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
Camberwell, VictoriaAges 18–59 - NCT07329621RecruitingPhase 1
Brain imaging study of MSP-2020 in healthy men
This study uses brain scans to see how well an experimental drug called MSP-2020 attaches to certain serotonin receptors in the brain. It may help researchers understand how this drug works in the body.
LondonAges 23–55 - NCT07369908Recruiting
Ear stimulation for anxiety and emotion control
This study tests whether a gentle, non-invasive electrical stimulation on the ear (called taVNS) can help lower anxiety and improve how you manage your emotions. It’s for healthy people who want to explore a potential new way to support emotional well-being.
Chengdu, SichuanAges 18–30 - NCT07375238Recruiting
Gazpacho daily for better sperm health
This study tests whether drinking gazpacho daily can improve sperm quality and reduce stress in the body. It may help men with low or abnormal sperm counts.
Madrid, MadridAges 18–45 - NCT07376200RecruitingPhase 1
First-in-human study of a new injection (HEC-151)
This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.
Chongqing, BishanAges 18–45 - NCT01467869Recruiting
Male fertility study for men with spinal cord injury
This study looks at fertility (the ability to father a child) in men who have a spinal cord injury. It compares them with healthy men to understand how spinal cord injury may affect fertility.
Miami, FloridaAges 18–50 - NCT00801372Recruiting
Using existing cells to make stem cells in adults
This study looks at using your existing skin or tissue cells to create special lab-grown stem cells. It may help researchers explore new ways to generate cells for future treatments.
Jerusalem, IsraelAges 18 years+ - NCT01194648Recruiting
HIFU treatment for early prostate cancer
This trial studies a focused ultrasound treatment called HIFU for prostate cancer that appears limited to the early stages. It aims to treat cancer within the prostate while avoiding treatment spread to lymph nodes or distant organs.
London, EnglandAges Up to 90 years - NCT02568878RecruitingPhase 3
Creatine to help depression and anxiety in meth users
This trial studies whether creatine can reduce depression and anxiety symptoms in people who currently use methamphetamine and also have depression and anxiety. It may help by improving mood and anxiety scores over the course of the study.
Missoula, MontanaAges 18–59 - NCT03180918Recruiting
Freezing testicular tissue before very fertility-damaging cancer treatment
This trial studies whether freezing a small piece of testicular tissue before certain aggressive cancer treatments can help preserve future fertility. It is meant for children or teens who face a high risk of infertility from specific treatments when usual sperm freezing is not possible.
BaselAges 3 months–18 years - NCT01248533Enrolling by invitation
Screening for abdominal aortic aneurysm in 65-year-old men in Oslo
This study is offering screening to check for an abdominal aortic aneurysm, a bulge in a major blood vessel in the belly. It may help find a problem early so it can be monitored or treated sooner if needed.
Ages 65–65 - NCT07407543RecruitingPhase 1
Study of SRN001 in healthy Korean and Caucasian men
This trial tests a new drug called SRN001 in healthy men to see how safe it is and how the body processes it. It may help find the right dose for future studies.
SeoulAges 19–60 - NCT07413666RecruitingPhase 1
Safety study of ORX489 in healthy adults
This phase 1 trial is testing an experimental drug called ORX489 in healthy adults aged 18 to 60. The goal is to see if it is safe and how the body processes it, which helps decide if it can be tried in people with certain conditions.
Lincoln, NebraskaAges 18–60 - NCT07425938Recruiting
How oxytocin affects emotional processing
This study looks at how oxytocin, a natural hormone, influences the way we process emotions. Healthy volunteers will receive oxytocin to understand its effects on emotion and brain activity.
Chengdu, SichuanAges 18–30 - NCT07439796RecruitingPhase 1
Study of ORN252 in healthy volunteers
This trial tests a new medicine called ORN252 in healthy people to see how safe it is. It helps researchers understand how the drug works before testing it in patients.
Herston, QueenslandAges 18–55 - NCT07444385RecruitingPhase 1
Safety study of two new drugs in healthy men
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
SeoulAges 19 years+ - NCT07456397Recruiting
AI to predict sperm success in IVF
This trial tests a new AI system that analyzes sperm to predict how well they might work in fertility treatments like IVF or ICSI. It aims to help doctors choose the best sperm for a successful pregnancy.
Barcelona, BarcelonaAges 18–60 - NCT07515235Recruiting
DMD Gene Variants and Heart Function in Young Males
This study examines how different genetic changes in the DMD gene affect heart function in boys with dystrophinopathy (a muscle-weakening condition). Understanding this connection may help doctors better monitor and treat heart problems in affected boys.
ThessalonikiAges 2–24 - NCT07619157RecruitingPhase 1
ONO-3310 Study for Kidney Disease and Type 2 Diabetes
This early-stage trial tests a new drug called ONO-3310 in two groups: healthy adults and people with kidney disease caused by type 2 diabetes. The study aims to understand how the drug works and whether it might help protect kidney function in people with diabetes.
Fukuoka, FukuokaAges 18–64 - NCT07627438Recruiting
Pelvic Floor Exercises for Premature Ejaculation
This trial tests whether targeted pelvic floor muscle exercises can help men with lifelong premature ejaculation last longer during intercourse. The study focuses on strengthening the muscles that control ejaculation through physical therapy techniques.
Tanta, TantaAges 18–50 - NCT07632300Recruiting
Two-phase IVM for poor ovarian response in women under 35
This trial tests a two-phase in-vitro maturation (IVM) method for women under 35 who had poor response to a previous IVF cycle (fewer than 4 eggs retrieved). The goal is to see if this approach helps get more usable eggs and embryos. You would need to freeze all embryos for later transfer.
Ho Chi Minh City, Hồ Chí MinhAges 18–35 - NCT07650955Recruiting
Two surgery approaches for enlarged veins affecting fertility
This trial compares two different surgical techniques to treat bilateral varicocele (enlarged veins in the scrotum) that may be causing infertility. The goal is to see which approach works better and causes fewer complications.
Banī Suwayf, Beni Suweif GovernorateAges 18–45 - NCT07666022RecruitingPhase 1
Safety study of MF1 for Parkinson's-related constipation
This early-phase study tests a new treatment called MF1 for Parkinson's-related symptoms, especially constipation. It first checks safety in healthy volunteers, then in people with Parkinson's who have slow bowel movements.
Sumida-ku, TokyoAges 18–85 - NCT07669584RecruitingPhase 2/Phase 3
Testing PKB171 for mild male infertility in couples
This study tests a new oral medication (PKB171) compared to a placebo for couples who have mild male infertility and have not tried IVF/ICSI before. The goal is to see if PKB171 can help them conceive naturally.
Pamplona, NavarreAges 18–38
Hear when a new Male trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for male?
- Yes. Clin2 currently lists 231 recruiting male studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a male trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a male trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.